Header Logo
Last Name

Michael George Machiorlatti

TitleAsst,Grad Research/Grad Col
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentBiostatistics & Epidemiology
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chen A, Machiorlatti M, Krebs NM, Muscat JE. Socioeconomic differences in nicotine exposure and dependence in adult daily smokers. BMC Public Health. 2019 Apr 03; 19(1):375. PMID: 30943945.
      View in: PubMed
    2. Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O'Connor DJ, Méndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019 01; 25(1):141-151. PMID: 30420753.
      View in: PubMed
    3. Mukherjee S, Ibrahimi S, Machiorlatti M, Roman D, Saleem R, Hassan A, Baxley A, Vesely S, Aljumaily R. Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study. Am J Ther. 2018 Nov/Dec; 25(6):e767-e768. PMID: 29746291.
      View in: PubMed
    4. Gutschenritter T, Machiorlatti M, Vesely S, Ahmad B, Razaq W, Razaq M. Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience. Anticancer Res. 2017 09; 37(9):5019-5025. PMID: 28870928.
      View in: PubMed
    5. Srour SA, Machiorlatti M, Pierson NT, Bhutta UZ, Cherry M, Selby GB, Thompson DM, Vesely SK, Kurkjian CD. Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2017 07; 17(7):450-456.e2. PMID: 28624543.
      View in: PubMed
    6. Couloures KG, Anderson M, Machiorlatti M, Marsenic O, Opas L. Discontinuation of Antimicrobial Prophylaxis (AP) in Children With Spina Bifida: A Case Series Analysis. Nephrourol Mon. 2016 Sep; 8(5):e38484. PMID: 27878110.
      View in: PubMed
    7. Rostaminia G, Machiorlatti M, Shobeiri SA, Quiroz LH. Variability of the pubic arch architecture and its influence on the minimal levator hiatus area. Int J Gynaecol Obstet. 2016 Aug; 134(2):217-20. PMID: 27177513.
      View in: PubMed
    8. Rostaminia G, Machiorlatti M, Omoumi F, Shobeiri SA. Statistical justifications for interrater reliability of levator ani deficiency (LAD) assessment by 3D endovaginal ultrasonography: response to critique. Int Urogynecol J. 2014 May; 25(5):709-10. PMID: 24595413.
      View in: PubMed
    9. Gunter T, Ali I, Matthiesen C, Machiorlatti M, Thompson D, Algan O. Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy. J Med Imaging Radiat Oncol. 2014; 58(3):384-91. PMID: 24592817.
      View in: PubMed
    Machiorlatti's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Same Department Expand Description